This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Social Bookmarking   What's this?

JAMA. 2002;287:655-656.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Physicians in the United States, Canada, and Mexico

Physicians with current and valid licenses in the United States, Canada, or Mexico who read any 3 of the selected continuing medical education (CME) articles in this issue of JAMA, complete the CME Evaluation Form, and fax it to the number or mail it to the address at the bottom of the CME Evaluation Form are eligible for category 1 CME credit. There is no charge.

The American Medical Association (AMA) is accredited by the Accreditation Council for Continuing Medical Education to sponsor CME for physicians. The AMA designates this educational activity for up to 1 hour of category 1 CME credit per JAMA issue toward the AMA Physician's Recognition Award (PRA). Each physician should claim for credit only those hours that were actually spent in this educational activity.

Physicians in Other Countries
Physicians with current and valid licenses in the United States, Mexico, or Canada are eligible for . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

Quality-of-Life and Depressive Symptoms in Postmenopausal Women After Receiving Hormone Therapy: Results From the Heart and Estrogen/Progestin Replacement Study (HERS) Trial
Mark A. Hlatky, Derek Boothroyd, Eric Vittinghoff, Penny Sharp, Mary A. Whooley, and for the HERS Research Group
JAMA. 2002;287(5):591-597.
ABSTRACT | FULL TEXT  

Effects of Diet and Simvastatin on Serum Lipids, Insulin, and Antioxidants in Hypercholesterolemic Men: A Randomized Controlled Trial
Antti Jula, Jukka Marniemi, Risto Huupponen, Arja Virtanen, Merja Rastas, and Tapani Rönnemaa
JAMA. 2002;287(5):598-605.
ABSTRACT | FULL TEXT  

Varicella Disease After Introduction of Varicella Vaccine in the United States, 1995-2000
Jane F. Seward, Barbara M. Watson, Carol L. Peterson, Laurene Mascola, Jan W. Pelosi, John X. Zhang, Teresa J. Maupin, Gary S. Goldman, Laura J. Tabony, Kimberly G. Brodovicz, Aisha O. Jumaan, and Melinda Wharton
JAMA. 2002;287(5):606-611.
ABSTRACT | FULL TEXT  

Relationships Between Authors of Clinical Practice Guidelines and the Pharmaceutical Industry
Niteesh K. Choudhry, Henry Thomas Stelfox, and Allan S. Detsky
JAMA. 2002;287(5):612-617.
ABSTRACT | FULL TEXT  

Long-term Efficacy of Platelet Glycoprotein IIb/IIIa Integrin Blockade With Eptifibatide in Coronary Stent Intervention
J. Conor O'Shea, Christopher E. Buller, Warren J. Cantor, A. Bleakley Chandler, Eric A. Cohen, David J. Cohen, Ian C. Gilchrist, Neal S. Kleiman, Marino Labinaz, Mina Madan, Gail E. Hafley, Robert M. Califf, Michael M. Kitt, John Strony, James E. Tcheng, and for the ESPRIT Investigators
JAMA. 2002;287(5):618-621.
ABSTRACT | FULL TEXT  

Nonspecific Medication Side Effects and the Nocebo Phenomenon
Arthur J. Barsky, Ralph Saintfort, Malcolm P. Rogers, and Jonathan F. Borus
JAMA. 2002;287(5):622-627.
ABSTRACT | FULL TEXT  

Medical Management of Advanced Heart Failure
Anju Nohria, Eldrin Lewis, and Lynne Warner Stevenson
JAMA. 2002;287(5):628-640.
ABSTRACT | FULL TEXT